RESI Boston 2026 Innovator’s Pitch Challenge Winners Announced

September 29, 2026 ~ Next Phase Admin ~ Leave a comment

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Life Science Nation is pleased to announce the winners of the RESI Boston 2026 Innovator’s Pitch Challenge, held during Biotech Week Boston.

Over the two days o RESI, more than 70 early stage life science companies presented their innovations to an audience of active investors, strategic partners, and industry leaders. Following the final round of pitches, the top three companies were recognized during lunch on day two:

1st Place	2nd Place	3rd Place

Synaptic Bio	Orthonika	Ironsides Medical

Congratulations to Synaptic Bio, Orthonika, Ironsides Medical, and every company that took the stage. The caliber of innovation, preparation, and investor engagement throughout the Challenge reflected the exciting work advancing across the global life science ecosystem.

Judges’ Picks Award Winners

In addition to the overall winners, Life Science Nation is proud to recognize the companies that received the highest evaluation scores from the investor judges in each Innovator’s Pitch Challenge session:

These companies stood out to the judging panels for the quality of their presentations and the potential of their technologies to address important unmet needs.

Apply to Pitch at RESI JPM 2027

Applications are now open for the Innovator’s Pitch Challenge at RESI JPM 2027, taking place in San Francisco on January 11 to 12, with virtual partnering January 13 and 18 to 19.

The Innovator’s Pitch Challenge gives early-stage companies the opportunity to present live to active life science investors, receive structured feedback, and build meaningful connections through RESI partnering.

Apply to the Innovator’s Pitch Challenge and secure your opportunity to pitch at RESI JPM.

Apply to Pitch at RESI JPM 2027

Secure Your Dedicated Session and Meeting Space at RESI JPM 2027

September 29, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

Every January, J.P. Morgan Healthcare Week transforms San Francisco into the global epicenter of life sciences, bringing together top-tier investors, corporate pharma scouts, and biotech innovators. For organizations seeking a visible, accessible base during the busiest week of the year, RESI JPM 2027 offers prime physical space inside the San Francisco Marriott Marquis.

Life Science Nation (LSN) is opening dedicated session and meeting spaces for booking across Monday, January 11 and Tuesday, January 12, 2027. Spaces can be reserved with flexible scheduling options: available by the hour, half-day, or full-day to accommodate presentations, private investor pitches, workshops, or ecosystem receptions. Additionally, hosting organizations receive official RESI JPM Sponsor status, featuring prominent brand exposure across RESI marketing and promotional channels.

Available Spaces and Layouts: Yerba Buena Ballroom (Lower B2 Level)

Located within LSN’s 17,000+ sq. ft. conference footprint across Salons 9–15:

Private Breakout Salons (Salons 10–15):

Size and Capacity: ~800 sq. ft. per room, seating up to 70 attendees.
Configuration: Fully enclosed private salons ideal for proprietary pitch sessions, closed-door investor roadshows, regional delegation showcases, or a private executive lounge.

Open Session Stage (Salon 9):

Size and Capacity: Open ballroom setting accommodating ~60 attendees.
Configuration: Positioned directly alongside the high-traffic partnering floor, maximizing foot traffic and casual walk-ins for open panel discussions and cohort spotlights.

Flexible Booking Windows (January 11–12, 2027)

Spaces are available throughout both in-person conference days:

Hourly Rentals: For focused company presentations, quick investor roundtables, or press briefings.
Half-Day Blocks (Morning / Afternoon): For structured cohort pitch sessions, seminars, or partner workshops.
Full-Day / Multi-Day Buyouts: To establish a dedicated branded headquarters and continuous meeting base right inside JPM week.

Immediate Next Steps

Contact LSN: Reach out directly to salescore@lifesciencenation.com to review specific floor plans, pricing tiers, and associated sponsor marketing packages.

RESI Boston 2026: Your Complete Conference Guide

September 15, 2026 ~ Next Phase Admin ~ Leave a comment

By Dennis Ford, Founder & CEO, Life Science Nation (LSN)

Life Science Nation (LSN) is pleased to release the RESI Boston 2026 Program Guide for the upcoming hybrid conference, taking place September 22–23 in person at the Westin Copley Place in Boston, followed by virtual partnering on September 25 and September 28–29.

Held during Biotech Week Boston, RESI brings together early-stage life science companies, active investors, strategic partners, and industry leaders for targeted fundraising and business development conversations. The event features the Innovator’s Pitch Challenge, investor panels, workshops, company showcases, and RESI Partnering, the conference’s purpose-built platform for scheduling one-on-one meetings.

The Program Guide offers a comprehensive look at the RESI Boston agenda, including sessions focused on the Boston biotech ecosystem, therapeutic innovation, pharma partnering, strategic capital, health systems, chronic disease care, family office investing, and impact investing. Attendees can also explore the participating investor, sponsor, exhibitor, and company lineup, along with networking opportunities throughout the event.

With partnering underway and meeting calendars continuing to fill in the final weeks before the conference, RESI Boston offers innovators a valuable opportunity to connect directly with investors and strategic stakeholders shaping the future of healthcare.

View the program guide and register for RESI Boston today.

Meet the Investor Judges at RESI Boston 2026

September 15, 2026 ~ Next Phase Admin ~ Leave a comment

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

RESI Boston brings together early-stage life science innovators and active investors during Biotech Week Boston. Life Science Nation is pleased to announce the investor judges participating in the Innovator’s Pitch Challenge (IPC).

This year’s IPC will feature more than 70 companies presenting across 20 pitch sessions over two days, offering startups a valuable opportunity to gain visibility, present directly to investors, and receive real-time feedback from experienced decision-makers.

Each pitch session will be evaluated by a panel of investor and strategic partner judges with expertise spanning therapeutics, medical devices, diagnostics, digital health, and life science tools. Companies will deliver a six-minute presentation followed by seven minutes of live investor Q&A, giving judges the opportunity to assess scientific differentiation, commercial potential, and investment readiness.

All IPC companies will also have a dedicated space in the RESI Exhibition Hall, creating additional opportunities for follow-up conversations and deeper engagement with investors and conference attendees.

RESI Boston attendees will be invited to vote with their RESI Cash for their favorite presenting companies. The Top 3 companies will be announced, with winners receiving prizes and additional exposure through the LSN Newsletter.

See the investors serving as judges for this year’s RESI Boston Innovator’s Pitch Challenge:

Featured RESI Boston IPC Judge
René Bastón Covenant Venture Capital	Caleb Bell Beyond Next Ventures	Randy Berholtz Mesa Verde Venture Partners
Shailesh Chavan Ingenious Global Venture Partners	Bruce Cohen Xeraya Capital	Yvette Ferreira Xcellerant Ventures
Navin Govind Evidence Ventures	Ole Henrik Bang Andreasen Avant Bio	Christopher Hupp Ipsen S.A.
Deepak Jha Autobahn Labs	James Lee Unistone Ventures	Claire Leurent AbbVie Ventures
Heather Loring AstraZeneca	James Massaquoi Glasswing Ventures	Mahesh Narayanan Neuvation Ventures
John Pennett Mid Atlantic Bio Angels	Garrett Peterson Yahara Ventures	Andrew Rae Woodgreen Ventures
Raza Shaikh Launchpad Venture Group	Justin Siemann Sontag Foundation	Sarah Tao CSL Behring
Martin Taylor F-Prime Capital	Lily Ting Lundbeck	Sally Wang Liang Xpanse Venture

RESI Boston Investor Speakers

September 9, 2026September 9, 2026 ~ Next Phase Admin ~ Leave a comment

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

RESI Boston brings together active early-stage investors and life science innovators for two days of investor-led programming focused on capital, partnering, and market dynamics shaping healthcare innovation.

The agenda will feature leading biotech VCs, family offices, corporate scouts, health system investors, and impact-focused investors sharing how they evaluate opportunities, where they see momentum, and what founders need to understand as they prepare to raise capital and build strategic partnerships.

From Boston’s biotech ecosystem and early-stage therapeutic investing to pharma partnering, health systems, strategic capital, chronic disease, women’s health, family offices, and impact investing, the panel program offers practical insight across the full life science financing landscape.

These conversations are designed to help entrepreneurs better understand investor priorities, refine their fundraising strategy, and build relationships with the people actively shaping the future of healthcare innovation.

RESI Boston takes place in person September 22–23 at the Westin Copley Place, with virtual partnering September 25 and September 28–29. Whether attending in Boston or virtually, participants can connect with investors, gain perspective from the panel stage, and advance their next conversations through targeted partnering.

Featured RESI Boston Investor Speakers
John Abeles Northlea Partners	Marc Appel Pacific Bridge NY	Farnaz Bakhshi ACS BrightEdge
Caleb Bell Beyond Next Ventures	Alan Chiu Breakthrough T1D	Scott Davis Sontag Foundation
Ronald Dorenbos BioFrontline Ltd.	Shane Duffy Avanos Medical, Inc.	Tao Fang MRL Ventures Fund (MRLV)
David Fogel Mass Medical Angels	Navin Govind Evidence Ventures	Nimisha Gupta Jazz Pharmaceuticals, Inc
William Hsu, PhD NuFund Venture Group	Austin Hwang Analog Garage	Jonathan Ilicki Industrifonden
Renaud Jacquemart Omnium Global	Rohit Jain HBS Alumni Angels of Northern California	Satoshi Konagai Astellas Venture Management (AVM)
Jason Kraus Boston Harbor Angels	Kathy Ku Sazze Partners	Sally Wang Liang Xpanse Venture
Nate Macht ACS BrightEdge	Nune Martiros Paladin Capital Group	Andrew Merken Polsinelli PC
Nikhil Mutyal AstraZeneca	Rohit Nuwal TELUS Ventures	Maggie O'Toole LabCentral
Soyoung Park 1004 Venture Partners	Dushyant Pathak Autobahn Labs	Garrett Peterson Yahara Ventures
Andrew Rae Woodgreen Ventures	Parthiban Rajasekaran Sanofi	Armin Rump Otsuka Pharmaceutical Co., Ltd.
Mo Soleja Golden Seeds	Yvanka de Soysa Foreground Capital	Daniel Teper YADAY Health
Andrew Thomson Ipsen S.A.	John Tremblay Launchpad Venture Group	Le Zhan Yunion Healthcare Ventures

The 2027 RESI Conference Lineup: Global Capital, Strategic Partnerships, and Life Science Innovation

September 9, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

The 2027 RESI Conference Lineup: Global Capital, Strategic Partnerships, and Life Science Innovation

Life Science Nation’s 2027 RESI conference calendar will connect early-stage life science companies with global investors, pharma partners, and industry leaders across four major life science hubs: San Francisco, Tokyo, Philadelphia, and Boston.

The year begins during JPM week and continues through Asia, BIO International Convention week in Philadelphia, and Boston’s biotech week in September. Each event is designed to help emerging companies build the investor relationships and strategic partnerships needed to move their companies forward.

RESI JPM 2027: January 11–12

San Francisco Marriott Marquis, San Francisco

Registration is now open for RESI JPM 2027.

Held concurrently with JPM Healthcare Week, RESI JPM brings early-stage companies into San Francisco during one of the world’s largest annual gatherings for healthcare investment and business development. The two-day in-person conference will be followed by virtual partnering on January 13, 18, and 19.

Previous RESI JPM conferences have drawn more than 1,000 attendees, including over 600 early-stage life science investors, innovators, and industry experts. For companies raising capital, pursuing strategic partnerships, or preparing for a major financing milestone, RESI offers a focused setting to make the most of the week.

RESI Asia Japan 2027: April 13

ANA InterContinental, Tokyo

RESI Asia Japan launches in collaboration with the Kobe Biomedical Innovation Cluster (KBIC), Japan’s largest biomedical cluster.

Japan represents one of the life science industry’s most valuable and least accessible markets. Its leading pharmaceutical companies are active licensors and acquirers of external innovation, while the country offers deep clinical development capabilities and a progressive regulatory pathway for regenerative medicine, cell therapy, and gene therapy.

RESI Asia Japan will create a direct bridge between Japan’s world-class science ecosystem and global capital and partnering networks. The event is part of a broader collaboration between Life Science Nation and KBIC focused on strengthening commercialization pathways, entrepreneur education, capital formation, and international business development for Japanese life science companies.

RESI Philadelphia 2027: June 7

Convene, Philadelphia

RESI Philadelphia will take place during BIO International Convention week, complementing the broader industry activity in the city with a dedicated forum for early-stage companies and active investors.

Philadelphia is a leading center for cell and gene therapy, biopharma, medical innovation, and academic research. RESI provides companies and investors attending BIO week with a targeted environment for investor partnering, live pitch opportunities, and conversations that can turn promising science into fundable, strategic opportunities.

Virtual partnering dates will be announced soon.

RESI Boston 2027: September 22

Westin Copley Place, Boston

RESI returns to Boston during biotech week, bringing the global early-stage life science investment community together in one of the world’s most important innovation hubs.

Boston’s unmatched concentration of founders, investors, academic institutions, biotech companies, and strategic partners makes it an essential stop on the RESI calendar. The in-person event will offer targeted partnering, investor panels, educational programming, and the Innovator’s Pitch Challenge for companies seeking to raise visibility and advance fundraising conversations.

Virtual partnering dates will be announced soon.

A Global RESI Run

The 2027 lineup offers companies multiple opportunities throughout the year to engage the Life Science Nation network, deepen relationships with investors and strategic partners, and access new regional markets.

RESI JPM: January 11–12, San Francisco
RESI Asia Japan: April 13, Tokyo
RESI Philadelphia: June 7, Philadelphia
RESI Boston: September 22, Boston

Registration is now open for RESI JPM 2027. Register by October 2 to save $900 with Super Early Bird pricing. Learn more at resiconference.com.

RESI Boston 2026 Innovator’s Pitch Challenge Finalists

September 1, 2026September 1, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

The Innovator’s Pitch Challenge (IPC) showcases early-stage companies developing breakthrough technologies across key sectors of life science and returns to RESI Boston with more than 65 innovative companies selected to pitch across 20 sessions over two days, September 22–23, 2026.

Each finalist will present to panels of active life science investors and industry leaders in sector-focused sessions spanning biotech, medtech, diagnostics, digital health, and more. The program gives fundraising companies the opportunity to share their technologies, receive practical feedback, and connect directly with investors and strategic partners seeking new opportunities.

For attendees, IPC is a chance to discover emerging companies and hear directly from the founders behind them. Finalists will also be available throughout the event exhibiting, networking, and attendees participating in partnering can schedule one-on-one meetings to continue the conversation.

Join Life Science Nation at RESI Boston during Biotech Week for two full days of company pitches, investor insights, and targeted partnering.

Meet the RESI Boston Innovator’s Pitch Challenge Finalists: